Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study.

Anna R Damato Jingqin R LuoRuth G N KatumbaGrayson R TalcottJoshua B Rubin Erik D Herzog Jian L Campian

Published in: Neuro-oncology advances (2021)

Our study presents preliminary evidence for the benefit of TMZ chronotherapy to GBM patient survival. This impact is more pronounced in MGMT-methylated patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
case report
peritoneal dialysis
patient reported
free survival